Guidelines for management of Bowen's disease: 2006 update.
about
Medical interventions for high-grade vulval intraepithelial neoplasiaInterventions for cutaneous Bowen's diseaseCutaneous lesions of the external ear.Bowen's disease treated by carbon dioxide laser. A series of 44 patients.2013 European guideline for the management of balanoposthitis.Histopathological variants of cutaneous squamous cell carcinoma: a review.Photodynamic therapy with ablative carbon dioxide fractional laser for treating Bowen diseaseEnvironmental scan of anal cancer screening practices: worldwide survey results.A randomized trial comparing methyl aminolaevulinate photodynamic therapy with and without Er:YAG ablative fractional laser treatment in Asian patients with lower extremity Bowen disease: results from a 12-month follow-up.Neoplasms of anal canal and perianal skin.Multiple Pigmented Bowen's Disease: A Diagnostic and Therapeutic Dilemma.Bowenoid transformation in seborrheic keratosis: A retrospective analysis of 429 patients.The important role of radiotherapy in patients with non-melanoma skin cancer and other cutaneous entities.Use of imiquimod 5% cream (Aldara) in cats with multicentric squamous cell carcinoma in situ: 12 cases (2002-2005).Bowen's disease - a review of newer treatment options.Anti-retroviral therapy's miracle in the treatment of Bowen's disease in a human immunodeficiency virus-positive patient: A rare case report.Malignancies of the anal margin and perianal skin.Human skin cancer stem cells: a tale of mice and men.Update on non-melanoma skin cancer and the value of dermoscopy in its diagnosis and treatment monitoring.Frequency of squamous cell carcinoma (SCC) invasion in transected SCC in situ referred for Mohs surgery: the Dartmouth-Hitchcock experience.Non-melanoma Skin Cancer in Canada Chapter 1: Introduction to the Guidelines.The Role of Interleukin-1 in Inflammatory and Malignant Human Skin Diseases and the Rationale for Targeting Interleukin-1 Alpha.Photodynamic therapy for dermatologic conditions in the pediatric population: a literature review.Neoadjuvant use of photodynamic therapy in Basal cell and squamous cell carcinomas of the face.Development of poorly differentiated invasive squamous cell carcinoma in giant Bowen's disease: a case report with dermatoscopy.Bowen's disease with features resembling myrmecia wart.Multiple-digit periungual Bowen's disease: a novel treatment approach with radiotherapy.Assessing physicians' preferences on skin cancer treatment in Europe.Fluorescence diagnosis and photodynamic therapy for Bowen's disease treatment.Bowen's disease: An unusual clinical presentation.Bowen's disease: A favorable response to imiquimod.Reflectance confocal microscopy: non-invasive distinction between actinic keratosis and squamous cell carcinoma.Periungual Bowen's disease in a 4-year-old girl.Successful treatment of periungual pigmented Bowen disease with CO2 laser.Combination of imiquimod with cryotherapy in the treatment of penile intraepithelial neoplasia.Trial of hyperthermic treatment for Bowen's disease with disposable chemical pocket warmers: A report of two cases.Effectiveness of photodynamic therapy in Bowen's disease: an observational and descriptive study in 51 lesions.British Association of Dermatologists' guidelines for the management of squamous cell carcinoma in situ (Bowen's disease) 2014.Does progression from actinic keratosis and Bowen's disease end with treatment: diclofenac 3% gel, an old drug in a new environment?Non-melanoma Skin Cancer in Canada Chapter 5: Management of Squamous Cell Carcinoma.
P2860
Q24187846-C87CF5F5-98D7-4E79-965A-682C7045C884Q24201818-7FEC06B7-972C-4DF8-9041-7C55DC027BF9Q33318965-7E1F5BA4-0B6D-4ECD-A9EA-EE30E7C931ADQ33401823-937DB498-D4D5-4E67-B24D-625FDB81C021Q34420017-3007EFCD-74BA-41FC-B18D-9E0F2E0E08F3Q34479227-3AB4D175-50B0-4A9B-8C47-A29DABAEFC72Q34977929-1CD761D8-FAFB-488C-8FB9-53E0000B5CEBQ35000536-32C2523B-DB50-4DE8-9C27-D338A03E8F68Q35010919-D5522B76-615B-4B39-8497-216EB0228468Q35117964-B85C2A7E-3183-4D2F-8896-E9C96F75DC18Q36344043-576B4844-6479-4B82-AD1A-044703F0D736Q36479926-08CEAF94-B790-4935-A3C9-5BB615420023Q37162640-B22748F6-1506-4876-8C62-D2A783680DD5Q37380110-42BBA6BE-8BCE-4CB7-B4D7-8305625A179AQ37390392-8D420EB3-5DC3-4295-A2B7-06FF674CCDA1Q37417211-691AF51A-B829-4F92-AB1C-E2E34359E9E3Q37427860-54A3D5D1-5193-4015-9CF0-6658C4CB191AQ38024864-93AC8B76-5B71-46FA-A82A-B778EA1CC51DQ38101606-255AB65E-517F-479C-B010-7556210E816BQ38446842-BEC0677A-7623-463B-8F35-6881234CF60EQ38504418-7E9515FB-F2E0-4900-AD70-287F91E2E094Q38948602-0A10D02A-A983-487A-B001-C6508C1CD461Q39107281-16CF6812-F9B7-4DF4-9A18-B17647E4BF62Q40546712-423000CD-F79B-488E-BD8E-93B68778C254Q41547435-B6DA08D3-9B9E-4CE7-B585-0F05D4EE8BE5Q41667438-D886C0AB-8B08-4357-AB0B-7B576F72AB06Q42277274-DE206B42-7221-4B77-822E-85917D2C0227Q42510992-AE2A78EF-D191-4290-85F5-99E1BF9DE98FQ42519543-B6F07C89-E60C-45AC-9036-C9D040DE5107Q43001984-A13A3FF9-3BAE-4B0B-ACB1-14CE871AC429Q43002007-CB42565E-2D61-45D5-B386-738E1232A2BEQ44115336-6B948192-F1BE-472E-8230-6958BFCB4377Q45302613-379A142B-4F38-4B7E-A701-10800E0F990CQ45968678-5FE6B692-AEB5-4F87-985A-6E32F5BFA6F1Q47134830-251DEEAA-FFCA-41F4-954A-403D3802E97EQ48120258-39A3DC5E-E8FF-44C6-9072-816BCA7AB0EFQ50529878-6BA4E132-FDF0-4E3D-A580-FDE26D1C6FEEQ51332124-870B503A-3656-46F7-A5C4-6175ACCD35B6Q52926194-E401C361-891A-4FC3-9F3D-1017D8F5C36DQ52947504-C95CE8F9-A64B-4221-8D64-E9419D5848D8
P2860
Guidelines for management of Bowen's disease: 2006 update.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Guidelines for management of Bowen's disease: 2006 update.
@ast
Guidelines for management of Bowen's disease: 2006 update.
@en
type
label
Guidelines for management of Bowen's disease: 2006 update.
@ast
Guidelines for management of Bowen's disease: 2006 update.
@en
prefLabel
Guidelines for management of Bowen's disease: 2006 update.
@ast
Guidelines for management of Bowen's disease: 2006 update.
@en
P2093
P2860
P1476
Guidelines for management of Bowen's disease: 2006 update.
@en
P2093
C A Morton
Therapy Guidelines and Audit Subcommittee, British Association of Dermatologists
P2860
P356
10.1111/J.1365-2133.2006.07610.X
P407
P577
2007-01-01T00:00:00Z